For youths in the first stage of drug use, where they have not yet used drugs, preventative measures are used. Therefore, limiting access to drugs, addressing any risk factors of the youth or family, as well as optimal parental supervision and expression regarding expectations is often recommended. The approach to those who have experimented with drugs is not minimized by drug treatment counselors, social workers, psychologists, psychiatrists, and other mental-health professionals, since infrequent use can progress to the more serious stages of use if not addressed. Therefore, professionals recommend that the youth be thoroughly educated about the effects and risks of drugs, receive fair but firm limits on the use of substances, and that the user be referred for brief counseling, a self-help group, and/or family support group. Teens that have progressed to the more advanced stages of drug addiction are typically treated intensively, often including inpatient drug treatment (drug rehab) and involves a combination of the medication, individual, and familial interventions already described above.
The original brand name of oxandrolone was Anavar, which was marketed in the United States and the Netherlands .   This product was eventually discontinued and replaced in the United States with a new product named Oxandrin, which is the sole remaining brand name for oxandrolone in the United States.   Oxandrolone has also been sold under the brand names Antitriol ( Spain ), Anatrophill ( France ), Lipidex ( Brazil ), Lonavar ( Argentina , Australia , Italy ), Protivar, and Vasorome ( Japan ) among others.     Additional brand names exist for products that are manufactured for the steroid black market.